YCM
ANIK icon

Yousif Capital Management’s Anika Therapeutics ANIK Stock Holding History

Yousif Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,962
Closed -$207K – 1982
2023
Q2 		$207K Sell
7,962
-368
-4% -$9.85K ﹤0.01% 1839
2023
Q1 		$239K Sell
8,330
-690
-8% -$20.5K ﹤0.01% 1780
2022
Q4 		$267K Sell
9,020
-2,585
-22% -$73.5K ﹤0.01% 1746
2022
Q3 		$276K Sell
11,605
-129
-1% -$2.97K ﹤0.01% 1716
2022
Q2 		$262K Sell
11,734
-1,165
-9% -$26K ﹤0.01% 1766
2022
Q1 		$324K Buy
12,899
+450
+4% +$13.7K ﹤0.01% 1775
2021
Q4 		$446K Buy
+12,449
New +$498K ﹤0.01% 1699

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return